ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 119,200
-1,200 (-1.00%)
At close: Dec 30, 2025
ST Pharm Market Cap
ST Pharm has a market cap or net worth of 2.49 trillion as of December 30, 2025. Its market cap has increased by 40.69% in one year.
Market Cap
2.49T
Enterprise Value
2.45T
Revenue
318.32B
Ranking
n/a
PE Ratio
67.07
Stock Price
119,200.00
Market Cap Chart
Since June 23, 2016, ST Pharm's market cap has increased from 902.04B to 2.49T, an increase of 176.32%. That is a compound annual growth rate of 11.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 2.49T | 39.24% |
| Dec 30, 2024 | 1.79T | 40.37% |
| Dec 28, 2023 | 1.28T | -22.60% |
| Dec 29, 2022 | 1.65T | -36.55% |
| Dec 30, 2021 | 2.60T | 34.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |